In summary, rosiglitazone may help control diabetes, but its serious impact on heart health makes it a risky choice. The Yale ...

A new study from Northwestern University has found that two widely prescribed type 2 diabetes medications—sulfonylureas and ...

Atrial Fibrillation (Afib) is a common, yet serious heart condition that requires proper diagnosis and management strategies.

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

The Food and Drug Administration (FDA) has added 17 drug products to its list of essential medication exempted from the 12 ...

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep.

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Wearable equipment-based telemedical management via multiparameter monitoring can help improve management in older patients with coronary heart disease.

New Delhi: India’s drug price regulator has capped the retail prices of 53 formulations or combinations of drugs used in treating pain, depression, diabetes, heart failure, and auto-immune diseases.

The programme includes the ECLIPSE 1 and ECLIPSE 2 Phase III trials, aiming to offer registrational data for regulatory ...

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI ...

Well-to-do and better-educated Americans have far lower rates of heart disease than the rest of the population, a new study ...